Skip to main content
Log in

Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

In more than 95% of cases acromegaly is due to GH hypersecretion by a pituitary adenoma. GHRH hypersecretion accounts for about 0.5% of cases of acromegaly. Intracranial GHRH-secreting tumors are extremely rare and only a few well-documented cases have been reported. The clinical features of acromegaly due to intracranial GHRH-secreting tumor are indistinguishable from those of other patients with “classical acromegaly”. In cases of intrasellar gangliocytomas, not even radiological findings help to make the correct diagnosis, which can only be made with the hystological study. We present the case of a woman with acromegaly; the magnetic resonance demonstrated a 2×1.8×1.2 cm mass in the jugum sphenoidalis region, associated with a partial empty sella. There was a partial response to high-dose lanreotide therapy, so surgical treatment was decided, although only part of the tumor could be removed. Histopathological diagnosis was consistent with gangliocytoma, and immunostaining in the ganglionic cells was positive for GHRH. After surgery, hormone hypersecretion persisted, so medical treatment was reintroduced. In summary, we report a well-documented case of an intracranial GHRH-secreting gangliocytoma, an exceedingly rare cause of acromegaly. Clinical and biochemical data did not allow to make the correct diagnosis, which was only made on the pathological study. This case underscores that acromegaly can be due to causes other than a GH-secreting adenoma, and underlines that finding an image not typical of a pituitary adenoma should raise the suspicion that an unusual cause subsides the acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reichlin S. Functional aspects of endocrine neoplasms. In: Kovacs K, Asa SL eds. Functional endocrine pathology. Boston: Blackwell Scientific Publications. 1991, 898–923.

    Google Scholar 

  2. von Werder K, Losa M, Stalla GK, et al. Measurement of human growth hormone- and corticotropin-releasing hormone. In: Faglia G, Beck-Peccoz P, Ambrosi B eds. Pituitary adenomas: new trends in basic and clinical research. Amsterdam: Elsevier Science BV. 1991, 215–29.

    Google Scholar 

  3. Faglia G, Arosio M, Bazzoni N. Ectopicacromegaly. Endocrinol Metab Clin North Am 1992, 21: 575–95.

    CAS  PubMed  Google Scholar 

  4. Losa M, von Werder K. Pathophysiology and clinical aspects of the ectopicGH-releasing hormone syndrome. Clin Endocrinol (Oxf) 1997, 47: 123–35.

    Article  CAS  Google Scholar 

  5. Asa SL, Scheithauer BW, Bilbao JM, et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone releasing factor. J Clin Endocrinol Metab 1984, 58: 796–803.

    Article  CAS  PubMed  Google Scholar 

  6. Kurosaki M, Saeger W, Ludecke DK. Intrasellar gangliocytomas associated with acromegaly. Brain Tumor Pathol 2002, 19: 63–7.

    Article  PubMed  Google Scholar 

  7. Geddes JF, Jansen GH, Robinson SF, et al. “Gangliocytomas” of the pituitary: a heterogeneous group of lesions with differing histiogenesis. Am J Surg Pathol 2000, 24: 607–13.

    Article  CAS  PubMed  Google Scholar 

  8. McCowen KC, Glickman JN, Black PM, Zervas NT, Garber JR. Gangliocytoma masquerading as a prolactinoma. Case report. J Neurosurg 1999, 91: 490–5.

    CAS  Google Scholar 

  9. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endoc Rev 1988, 9: 357–73.

    Article  CAS  Google Scholar 

  10. Puchner MJ, Ludecke DK, Saeger W, Riedel M, Asa SL. Gangliocytomas of the sellar region- a review. Exp Clin Endocrinol Diabetes 1995, 103: 129–49.

    Article  CAS  PubMed  Google Scholar 

  11. Luna V, Morales F, Luengo LM, Sanz A, Diaz J. Pituitary gangliocytoma-adenoma presenting with acromegaly: response to treatment. Arch Intern Med 2001; 161: 1010–1.

    Article  CAS  PubMed  Google Scholar 

  12. Cavalla P, Schiffer D. Neuroendocrine tumors in the brain. Ann Oncol 2001, 12(Suppl. 2): S131–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Cordido MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Isidro, M.L., Díaz, P.I., Matías-Guiu, X. et al. Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma. J Endocrinol Invest 28, 162–165 (2005). https://doi.org/10.1007/BF03345360

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345360

Key-words

Navigation